Stem Cell Therapy for Lupus (SLE)
- Written by
- StemCell Longevita Editorial Team
- Medically reviewed by
- Prof. Dr. Erdal Karaöz TeamProfessor of Histology and Embryology · Medical Director, Center for Regenerative Medicine
- Last reviewed
- Next scheduled review
How we evaluate evidence · Conflict-of-interest disclosure · Editorial standards
Advanced MSC treatments resetting the dysregulated immune system, suppressing autoreactive cells, reducing inflammatory cytokines, and protecting vital organs from autoimmune damage.
Can stem cell therapy help systemic lupus erythematosus?
Mesenchymal stem cell therapy is not an approved treatment for systemic lupus erythematosus. Small early-phase studies in refractory lupus have reported acceptable safety and some biomarker changes, but they have not demonstrated a consistent, replicated clinical benefit versus standard care. Disease-modifying therapy — hydroxychloroquine, immunosuppressants, biologics such as belimumab or anifrolumab where eligible — remains the evidence-based mainstay.
Key facts
- Approval status
- Not approved for lupus
- Evidence
- Small refractory-lupus series; not replicated at scale
- Standard care
- HCQ, immunosuppression, belimumab/anifrolumab in selected patients
What we know
- MSC administration in refractory lupus has met short-term safety endpoints in reported studies.
What remains uncertain
- Whether reported responses persist and whether they exceed standard escalation of immunosuppression.
Medically reviewed questions
This summary is general medical information, not medical advice, and not a promise of benefit. Figures are quoted ranges, confirmed in writing after a medical review.
Medically reviewed by: Prof. Dr. Erdal Karaöz · Last updated: · Editorial and evidence policy
Evidence at a glance — Systemic lupus erythematosus
A plain summary of what the published research does and does not show for this condition. It is written to the same standard whether the evidence is strong or weak.
- Human studies available?
- Yes — early-stage only
- Randomised trials?
- Small randomised and controlled trials, mainly from single centres
- Main outcomes studied
- SLEDAI disease activity
- Proteinuria
- Steroid dose
- Safety
- Long-term evidence
- Very limited
- Regulatory approval for this indication
- United States (FDA): No FDA-approved mesenchymal stem cell product for this indication. The FDA has issued consumer warnings about unapproved stem cell products.
- European Union (EMA): No EMA-authorised mesenchymal stem cell medicine for this indication.
- United Kingdom (MHRA): No MHRA-authorised mesenchymal stem cell medicine for this indication.
- Türkiye (Ministry of Health): In Türkiye, cell therapies are delivered only inside Ministry of Health–licensed centres under the regenerative medicine / advanced therapy regulations, as clinical research or individual (exceptional) use — not as an approved routine treatment for this indication.
- Role at our centre
- Research context — considered only where standard care is exhausted or unsuitable, and never as a replacement for it
What kind of evidence exists
- Mechanism (laboratory): Documented
- Animal / preclinical: Documented
- Early human (phase 1/2, uncontrolled): Documented
- Controlled human (randomised or sham-controlled): Documented
- Regulatory approval: Not established
Sources
- Systematic reviews and meta-analyses — Systemic lupus erythematosus — PubMed
- Randomised controlled trials — Systemic lupus erythematosus — PubMed
- Registered MSC trials — Systemic lupus erythematosus — ClinicalTrials.gov
- FDA — Consumer alert on regenerative medicine therapies — U.S. Food and Drug Administration, 2024
- Advanced therapy medicinal products: overview — European Medicines Agency, 2025
- ISSCR Guidelines for Stem Cell Research and Clinical Translation — International Society for Stem Cell Research, 2021
- ISSCR Patient Handbook on Stem Cell Therapies — International Society for Stem Cell Research, 2020
Source links open filtered searches of PubMed and ClinicalTrials.gov plus regulator and professional-society pages, so you can read the current evidence yourself rather than a selected extract.
This summary is general information about the evidence base, not medical advice and not a promise of benefit. Whether any treatment is appropriate for you can only be decided after a medical review of your records.
What is Lupus (SLE)?
Systemic lupus erythematosus (SLE) is a complex autoimmune disease in which the immune system attacks healthy tissue throughout the body, affecting joints, skin, kidneys, brain, and other organs. It affects approximately 5 million people worldwide, predominantly women of reproductive age.
Conventional treatment relies on immunosuppressive medications and corticosteroids that help manage symptoms but come with significant long-term side effects. MSC therapy offers a novel approach by resetting the immune system's balance rather than broadly suppressing it.
At StemCell Longevita, our MSC protocols for lupus are informed by published clinical research showing that allogeneic MSC transplantation can significantly reduce disease activity scores, improve kidney function in lupus nephritis, and allow reduction of immunosuppressive medications.
Ideal Candidates
- Patients with active systemic lupus erythematosus
- Those with lupus nephritis or organ involvement
- Patients experiencing frequent lupus flares despite medication
- Individuals seeking to reduce steroid or immunosuppressive dependence
- Patients with refractory lupus not responding to conventional therapies
How Stem Cell Therapy Helps Lupus (Systemic Lupus Erythematosus)
Immune System Reset
MSCs suppress autoreactive T and B cells while promoting regulatory T-cell generation, fundamentally rebalancing the dysregulated immune system in lupus.
Organ Protection
By reducing autoimmune activity, MSC therapy helps protect kidneys, brain, heart, and other organs from ongoing autoimmune-mediated damage.
Flare Reduction
Clinical studies show MSC therapy reduces SLEDAI disease activity scores and decreases the frequency and severity of lupus flares for 12+ months.
Medication Reduction
Many patients are able to reduce their steroid and immunosuppressive medication doses under medical supervision following successful MSC treatment.
Treatment Process
Your step-by-step treatment journey at StemCell Longevita
Lupus Assessment
SLEDAI scoring, organ involvement evaluation, antibody panel, complement levels, and comprehensive immune profiling.
Protocol Customization
Tailored treatment plan based on disease activity, organ involvement, current medications, and specific lupus manifestations.
MSC Preparation
Allogeneic Wharton's jelly MSCs with proven immunomodulatory potency prepared in our GMP-certified laboratory.
IV Administration
Intravenous MSC infusion delivering 50-100 million cells for systemic immune modulation and autoimmune suppression.
Disease Monitoring
SLEDAI scoring, kidney function tests, and antibody levels tracked at 1, 3, 6, and 12 months post-treatment.
Patient Experiences
Real outcomes from patients who chose regenerative medicine at StemCell Longevita Istanbul
"My rheumatologist was surprised by the improvement. I can hold my grandchildren's hands again without wincing — that means everything to me."
"Lupus controlled my life for a decade. After treatment in Istanbul, I travelled to three countries in one month — something unimaginable a year ago."
Frequently Asked Questions
All Regenerative Medicine Applications
Explore our comprehensive range of regenerative medicine applications for various conditions. Click any option to learn more.
Related Treatments
Related Articles
Explore our in-depth research articles and guides on related treatments and therapies.
Regenerative Approaches for Autoimmune Conditions: Research & Outcomes
Research on how mesenchymal stem cell approaches modulate the immune system to address autoimmune conditions including lupus, rheumatoid arthritis, and Crohn's disease.
Read ArticleUnderstanding Regenerative Medicine: A Complete Guide
A comprehensive overview of stem cell therapy, including types of stem cells, care processes, safety considerations, and what patients can expect during their wellness journey.
Read ArticleExosome Therapy: The Next Frontier in Regenerative Medicine
Learn about exosome therapy and how these powerful cellular messengers are being studied to support tissue repair, reduce inflammation, and support overall wellness processes.
Read ArticleRelated clinical questions
Where this page sits in the wider picture.